Pharma IQ | 07/22/2010
Dr. Franz Hessel, Director of International Health Economics Outcomes Research at Abbott, talks to Andrea Charles from Pharma IQ, about the approaches authorities in leading pharmaceutical markets have taken to the use of Health Technology Assessment (HTA) and how he thinks HTA will develop over the next few years.
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More